WESTFIELD CAPITAL MANAGEMENT CO LLC 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-11 09:15 am Purchase |
2024-12-31 | 13G | Ascendis Pharma A/S ASND |
WESTFIELD CAPITAL MANAGEMENT CO LLC | 5,528,239 9.180% |
1,453,025 (+35.66%) |
Filing |
| 2025-02-10 5:13 pm Purchase |
2024-12-31 | 13G | Ascendis Pharma A/S ASND |
WESTFIELD CAPITAL MANAGEMENT CO LLC | 4,075,214 9.180% |
44,580 (+1.11%) |
Filing |
| 2024-02-02 1:18 pm Purchase |
2023-12-29 | 13G | Ascendis Pharma A/S ASND |
WESTFIELD CAPITAL MANAGEMENT CO LLC | 4,030,634 7.050% |
872,466 (+27.63%) |
Filing |
| 2023-02-01 7:36 pm Purchase |
2022-12-30 | 13G | Ascendis Pharma A/S ASND |
WESTFIELD CAPITAL MANAGEMENT CO LLC | 3,158,168 5.540% |
3,158,168 (New Position) |
Filing |